ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Ovarian Cancer

Breast Cancer trials near San Antonio, TX, USA:

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...

Enrolling
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Capecitabine
Drug: PCS6422 and capecitabine

Phase 2

Processa Pharmaceuticals

San Antonio, Texas, United States and 8 other locations

The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...

Enrolling
Metastatic Breast Cancer
Drug: fulvestrant
Drug: PMD-026

Phase 1, Phase 2

Phoenix Molecular Designs

San Antonio, Texas, United States of America and 7 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

San Antonio, Texas, United States and 47 other locations

growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...

Enrolling
Metastatic Breast Cancer
Drug: Elacestrant

Phase 2

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 33 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Active, not recruiting
Breast Cancer
Locally Advanced Breast Cancer
Drug: Elacestrant Dihydrochloride
Drug: Samuraciclib

Phase 1, Phase 2

Carrick Therapeutics

San Antonio, Texas, United States and 22 other locations

growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to:* Learn how well...

Enrolling
Breast Cancer
Drug: Tucatinib
Drug: Doxil

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 7 other locations

endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast...

Enrolling
Breast Cancer
Drug: Elacestrant
Drug: Tamoxifen

Phase 3

Stemline Therapeutics
Stemline Therapeutics

New Braunfels, Texas, United States and 44 other locations

The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations in patients with ER+/HER2- advanced/metastatic breast...

Enrolling
Breast Cancer
Metastatic Breast Cancer
Drug: Elacestrant
Drug: Everolimus

Phase 1, Phase 2

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 115 other locations

This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...

Enrolling
Advanced Breast Cancer
Drug: Elacestrant
Drug: MEN2312

Phase 1

Stemline Therapeutics
Stemline Therapeutics

San Antonio, Texas, United States and 19 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States of America and 55 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems